Krystal Biotech, Inc.

May 16, 2026 • Author: Phil Ratcliff

Item	Proposal	Vote
1	Election of Class III Directors
1.01	Krish S. Krishnan	✗ Against(100.677)
1.02	Christopher Mason	✓ For(100.677)
2	To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.	✓ For(100.677)
3	Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.	✓ For(100.677)
4	Approval of the Company's Non-Employee Director Compensation Policy.	✓ For(100.677)

Attachments

📄

KRYS_Proxy_Statement.pdf 0.8 MB

📄

KRYS_Annual_Report_2025.pdf 34.0 MB

This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.